Most CRISPR assays lack clinical utility due to their complex workflows and limited validation. Here we present a streamlined “one-pot” asymmetric CRISPR tuberculosis assay that attenuates amplicon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results